Artery Research
Volume 2, Issue 1 , Pages 21-34 , February 2008

Identifying the vulnerable plaque: A review of invasive and non-invasive imaging modalities

  • Jan G. Kips

      Affiliations

    • Cardiovascular Mechanics and Biofluid Dynamics, Institute Biomedical Technology, Gent University, Gent, Belgium
    • Heymans Institute for Pharmacology, Gent University, Gent, Belgium
    • ,
  • Patrick Segers

      Affiliations

    • Cardiovascular Mechanics and Biofluid Dynamics, Institute Biomedical Technology, Gent University, Gent, Belgium
    • ,
  • Luc M. Van Bortel

      Affiliations

    • Heymans Institute for Pharmacology, Gent University, Gent, Belgium
    • Corresponding Author InformationCorresponding author. Heymans Institute for Pharmacology, Gent University, De Pintelaan 185, B-9000 Gent, Belgium.

Received 29 June 2007 ,Revised 21 November 2007 ,Accepted 27 November 2007.

References 

  1. Vaina S, Stefanadis C. Detection of the vulnerable coronary atheromatous plaque. Where are we now?. Int J Cardiovasc Intervent. 2005;7(2):75–87
  2. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol. 2003;41(4 Suppl. S):15S–22S
  3. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis – the good, the bad, and the ugly. Circulation Res. 2002;90(3):251–262
  4. Davies MJ. Stability and instability: two faces of coronary atherosclerosis – the Paul Dudley White Lecture 1995. Circulation. 1996;94(8):2013–2020
  5. Davies JR, Rudd JF, Fryer TD, Weissberg PL. Targeting the vulnerable plaque: the evolving role of nuclear imaging. J Nucl Cardiol. 2005;12(2):234–246
  6. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity – patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998;18(3):333–338
  7. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104(3):365–372
  8. Hao HY, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity – implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 2003;23(9):1510–1520
  9. Rudd JH, Davies JR, Weissberg PL. Imaging of atherosclerosis – can we predict plaque rupture?. Trends Cardiovasc Med. 2005;15(1):17–24
  10. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient – a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108(14):1664–1672
  11. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001;89(4):305–316
  12. MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK. Intravascular modalities for detection of vulnerable plaque: current status. Arterioscler Thromb Vasc Biol. 2003;23(8):1333–1342
  13. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93(7):1354–1363
  14. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death – a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262–1275
  15. Schroeder AP, Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis. 1995;118(Suppl):S141–S149
  16. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92(3):657–671
  17. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12(1):56–62
  18. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, et al. Can coronary angiography predict the site of a subsequent myocardial-infarction in patients with mild-to-moderate coronary-artery disease. Circulation. 1988;78(5):1157–1166
  19. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary-arteries. N Engl J Med. 1987;316(22):1371–1375
  20. Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, et al. Arterial enlargement in the atherosclerosis risk in communities (Aric) cohort – in-vivo quantification of carotid arterial enlargement. Stroke. 1994;25(7):1354–1359
  21. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92(5):1355–1374
  22. Landini L, Santarelli MF, Pingitore A, Positano V. New technological developments in the clinical imaging of atherosclerotic plaque. Curr Pharm Des. 2003;9(29):2403–2415
  23. Galbraith JE, Murphy ML, Desoyza N. Coronary angiogram interpretation – interobserver variability. Jama-J Am Med Assoc. 1978;240(19):2053–2056
  24. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation. 1976;53(4):627–632
  25. Topol EJ, Nissen SE. Our preoccupation with coronary luminology – the dissociation between clinical and angiographic findings in ischemic-heart-disease. Circulation. 1995;92(8):2333–2342
  26. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001;103(4):604–616
  27. Hiro T, Leung CY, deGuzman S, Caiozzo VJ, Farvid AR, Karimi H, et al. Are soft echoes really soft? Intravascular ultrasound assessment of mechanical properties in human atherosclerotic tissue. Am Heart J. 1997;133(1):1–7
  28. Peters RJ, Kok WE, Havenith MG, Rijsterborgh H, van der Wal AC, Visser CA. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr. 1994;7(3 Pt 1):230–241
  29. Stone GW, Hodgson JM, Stgoar FG, Frey A, Mudra H, Sheehan H, et al. Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing – The CLOUT pilot trial. Circulation. 1997;95(8):2044–2052
  30. Carlier SG, Tanaka K. Studying coronary plaque regression with IVUS: a critical review of recent studies. J Interv Cardiol. 2006;19(1):11–15
  31. Machado JC, Foster FS. Ultrasonic integrated backscatter coefficient profiling of human coronary arteries in vitro. IEEE Trans Ultrason Ferroelectr Freq Control. 2001;48(1):17–27
  32. Kawasaki M, Takatsu H, Noda T, Ito Y, Kunishima A, Arai M, et al. Non-invasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesions using ultrasound integrated backscatter – comparison between histology and integrated backscatter images. J Am College Cardiol. 2001;38(2):486–492
  33. Sano K, Kawasaki M, Ishihara Y, Mao M, Tsuchlya K, Nishigaki K, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2006;47(4):734–741
  34. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002;106(17):2200–2206
  35. Konig A, Klauss V. Virtual histology. Heart. 2007;93(8):977–982
  36. Moore MP, Spencer T, Salter DM, Kearney PP, Shaw TRD, Starkey IR, et al. Characterisation of coronary atherosclerotic morphology by spectral analysis of radiofrequency signal: in vitro intravascular ultrasound study with histological and radiological validation. Heart. 1998;79(5):459–467
  37. Nair A, Calvetti D, Vince DG. Regularized autoregressive analysis of intravascular ultrasound backscatter: improvement in spatial accuracy of tissue maps. IEEE Trans Ultrason Ferroelectr Freq Control. 2004;51(4):420–431
  38. Diethrich EB, Margolis MP, Reid DB, Burke A, Ramaiah V, Rodriguez-Lopez JA, et al. Virtual histology intravascular ultrasound assessment of carotid artery disease: The Carotid Artery Plaque Virtual histology evaluation (CAPITAL) study. J Endovasc Ther. 2007;14(5):676–686
  39. Cespedes I, Ophir J, Ponnekanti H, Maklad N. Elastography – elasticity imaging using ultrasound with application to muscle and breast in-vivo. Ultrason Imag. 1993;15(2):73–88
  40. Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography – a quantitative method for imaging the elasticity of biological tissues. Ultrason Imag. 1991;13(2):111–134
  41. Schaar JA, van der Steen AFW, Mastik F, Baldewsing RA, Serruys PW. Intravascular palpography for vulnerable plaque assessment. J Am Coll Cardiol. 2006;47(8):C86–C91
  42. De Korte CL, Sierevogel MJ, Mastik F, Strijder C, Schaar JA, Velema E, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo A Yucatan pig study. Circulation. 2002;105(14):1627–1630
  43. De Korte CL, Pasterkamp G, van der Steen AFW, Woutman HA, Bom N. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation. 2000;102(6):617–623
  44. Schaar JA, Mastik F, Regar E, den Uil CA, Gijsen FJ, Wentzel JJ, et al. Current diagnostic modalities for vulnerable plaque detection. Curr Pharm Des. 2007;13(10):995–1001
  45. Schaar JA, Regar E, Mastik F, McFadden EP, Saia F, Disco C, et al. Incidence of high-strain patterns in human coronary arteries – assessment with three-dimensional intravascular palpography and correlation with clinical presentation. Circulation. 2004;109(22):2716–2719
  46. Teirstein PS, Schatz RA, Denardo SJ, Jensen EE, Johnson AD. Angioscopic versus angiographic detection of thrombus during coronary interventional procedures. Am J Cardiol. 1995;75(16):1083–1087
  47. Uretsky BF, Denys BG, Counihan PC, Ragosta M. Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects – comparison to angiography. Cathet Cardiovasc Diagn. 1994;33(4):323–329
  48. Uchida Y, Nakamura F, Tomaru T, Morita T, Oshima T, Sasaki T, et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J. 1995;130(2):195–203
  49. Stefanadis C, Vavuranakis M, Toutouzas P. Vulnerable plaque: the challenge to identify and treat it. J Interv Cardiol. 2003 Jun;16(3):273–280
  50. Miyamoto A, Prieto AR, Friedl SE, Lin FC, Muller JE, Nesto RW, et al. Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque. Clin Cardiol. 2004;27(1):9–15
  51. Cademartiri F, La Grutta L, Palumbo A, Maffei E, Aldrovandi A, Malago R, et al. Imaging techniques for the vulnerable coronary plaque. Radiol Med. 2007;112(5):637–659
  52. Manfrini O, Mont E, Leone O, Arbustini E, Eusebi V, Virmani R, et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol. 2006;98(2):156–159
  53. Kawasaki M, Bouma BE, Bressner J, Houser SL, Nadkarni SK, MacNeill BD, et al. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol. 2006;48(1):81–88
  54. Yabushita H, Bourna BE, Houser SL, Aretz T, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106(13):1640–1645
  55. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction – ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50(10):933–939
  56. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, et al. Focal and multi-focal plaque distributions in patients with macrophage acute and stable presentations of coronary artery disease. J Am Coll Cardiol. 2004;44(5):972–979
  57. Yun SH, Tearney GJ, Vakoc BJ, Shishkov M, Oh WY, Desjardins AE, et al. Comprehensive volumetric optical microscopy in vivo. Nat Med. 2006;12(12):1429–1433
  58. Brezinski M. Characterizing arterial plaque with optical coherence tomography. Curr Opin Cardiol. 2002;17(6):648–655
  59. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347(9013):1447–1449
  60. Stefanadis C, Toutouzas K, Tsiamis E, Stratos C, Vavuranakis M, Kallikazaros I, et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol. 2001;37(5):1277–1283
  61. Madjid M, Willerson JT, Casscells SW. Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol. 2006 Apr 18;47(Suppl. 8):C80–C85
  62. Verheye S, Van Langenhove G, Diamantopoulos L, Serruys PW, Vermeersch P. Temperature heterogeneity is nearly absent in angiographically normal or mild atherosclerotic coronary segments: interim results from a safety study. Am J Cardiol. 2002;90(6A):24H
  63. Moreno PR, Lodder RA, Purushothaman KR, Charash WE, O'Connor WN, Muller JE. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation. 2002;105(8):923–927
  64. Romer TJ, Brennan JFI, Puppels GJ, Zwinderman AH, van Duinen SG, van der LA, et al. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):478–483
  65. Bhatia V, Bhatia R, Dhindsa S, Dhindsa M. Imaging of the vulnerable plaque: new modalities. South Med J. 2003 Nov;96(11):1142–1147
  66. van de Poll SW, Romer TJ, Puppels GJ, van der LA. Raman spectroscopy of atherosclerosis. J Cardiovasc Risk. 2002 Oct;9(5):255–261
  67. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340(1):14–22
  68. Hollander M, Hak AE, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, et al. Comparison between measures of atherosclerosis and risk of stroke – The Rotterdam Study. Stroke. 2003;34(10):2367–2372
  69. Hoeks APG, Brands PJ, Smeets FAM, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol. 1990;16(2):121–128
  70. Hiltawsky KM, Wiegratz A, Enderle MD, Ermert H. Real-time detection of vessel diameters with ultrasound. Biomed Technik. 2003;48(5):141–146
  71. Nederkoorn PJ, van der Graaf Y, Hunink M. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis – a systematic review. Stroke. 2003;34(5):1324–1331
  72. James G, Raggi P. Electron beam tomography as a non-invasive method to monitor effectiveness of antiatherosclerotic therapy. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4(2):177–181
  73. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228(3):826–833
  74. Escolar E, Weigold G, Fuisz A, Weissman NJ. New imaging techniques for diagnosing coronary artery disease. Can Med Assoc J. 2006;174(4):487–495
  75. Cordeiro MAS, Lima JAC. Atherosclerotic plaque characterization by multidetector row computed tomography angiography. J Am Coll Cardiol. 2006;47(8):C40–C47
  76. Pohle K, Achenbach S, MacNeill B, Ropers D, Ferencik M, Moselewski F, et al. Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis. 2007;190(1):174–180
  77. Saba L, Sanfilippo R, Pirisi R, Pascalis L, Montisci R, Mallarini G. Multidetector-row CT angiography in the study of atherosclerotic carotid arteries. Neuroradiology. 2007;49(8):623–637
  78. Romano M, Mainenti PP, Imbriaco M, Amato B, Markabaoui K, Tamburrini O, et al. Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement. Eur J Radiol. 2004;50(3):303–308
  79. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque – Part II: approaches by non-invasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005;46(7):1209–1218
  80. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000;102(9):959–964
  81. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta – a comparison with transesophageal echocardiography. Circulation. 2000;101(21):2503–2509
  82. Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KCP, Steinman L. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol. 2000;104(1):1–9
  83. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, et al. Non-invasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998;98(15):1541–1547
  84. Fayad ZA, Hardy CJ, Giaquinto R, Kini AS, Fuster V. Improved high resolution MRI of human coronary lumen and plaque with a new cardiac coil. Circulation. 2000;102(18):399
  85. Klein IF, Lavallee PC, Touboul PJ, Schouman-Claeys E, Amarenco P. In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology. 2006;67(2):327–329
  86. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque – emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol. 2002;22(7):1065–1074
  87. Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEH, Borgers M, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107(19):2453–2458
  88. Trivedi RA, Mallawarachi C, King-Im JM, Graves MJ, Horsley J, Goddard MJ, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol. 2006;26(7):1601–1606
  89. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005;25(1):234–239
  90. Herborn CU, Vogt FM, Lauenstein TC, Dirsch O, Corot C, Robert P, et al. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide. J Magn Reson Imag. 2006;24(2):388–393
  91. Lipinski MJ, Frias JC, Fayad ZA. Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage. J Nucl Cardiol. 2006;13(5):699–709
  92. Davies JR, Rudd JHF, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol. 2006;47(8):C57–C68
  93. Phelps ME, Hoffman EJ, Selin C, Huang SC, Robinson G, Macdonald N, et al. Investigation of [F-18] 2-fluoro-2-deoxyglucose for measure of myocardial glucose-metabolism. J Nucl Med. 1978;19(12):1311–1319
  94. Rudd JHF, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [F-18]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708–2711
  95. Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. F-18-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45(7):1245–1250
  96. Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol. 1999;6(1):41–53
  97. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229(3):831–837

PII: S1872-9312(07)00176-7

doi: 10.1016/j.artres.2007.11.002

Artery Research
Volume 2, Issue 1 , Pages 21-34 , February 2008

Article Tools

* Image Usage & Resolution